Next-generation AAV gene therapy targets intractable chronic pain SAN DIEGO, Feb. 4, 2025 /PRNewswire/ — Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M Translational Science grant from CIRM for the relief of…
